CD44 and breast carcinoma: Separately, breast cancer stem cells, identified prospectively as tumor initiating cells when transplanted into immunodeficient mice, have been characterized by the surface expression phenotype CD44+/CD24−/low[40], also a presumed phenotype of normal breast epithelial stem or early progenitor cells [84].